The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients:: comparison with observed events in the D:A:D Study

被引:222
作者
Law, MG
Friis-Moller, N
El-Sadr, WM
Weber, R
Reiss, P
Monforte, AD
Thiébaut, R
Morfeldt, L
De Wit, S
Pradier, C
Calvo, G
Kirk, O
Sabin, CA
Phillips, AN
Lundgren, JD
机构
[1] UNSW, Natl Ctr HIV Epidemiol & Clin Res, AHOD, Sydney, NSW, Australia
[2] Hvidovre Univ Hosp, Copenhagen HIV Programme, Copenhagen, Denmark
[3] Columbia Univ, Harlem Hosp, CPCRA, New York, NY USA
[4] Univ Zurich Hosp, SHCS, CH-8091 Zurich, Switzerland
[5] Univ Amsterdam, Acad Med Ctr, HIV Monitoring Fdn, ATHENA, NL-1105 AZ Amsterdam, Netherlands
[6] Univ Milan, L Sacco Hosp, ICONA, Milan, Italy
[7] Bordeaux Univ Hosp, Aquitaine Cohort, INSERM, U593, Bordeaux, France
[8] Karolinska Hosp, HivBivus, S-10401 Stockholm, Sweden
[9] CHU St Pierre Hosp, St Pierre Cohort, Brussels, Belgium
[10] CHU Nice Hop Archet, Nice Cohort, Nice, France
[11] Autonomous Univ Barcelona, BASS, Barcelona, Spain
[12] Hvidovre Univ Hosp, CHIP, EuroSIDA, Copenhagen, Denmark
[13] UCL Royal Free & Univ Coll Med Sch, Royal Free Ctr HIV Med, London, England
[14] UCL Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, London, England
关键词
antiretroviral therapy; Framingham risk equation; myocardial infarction;
D O I
10.1111/j.1468-1293.2006.00362.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background The D:A:D (Data Collection on Adverse Events of Anti-HIV Drugs) Study, a prospective observational study on a cohort of 23 468 patients with HIV infection, indicated that the incidence of myocardial infarction (MI) increased by 26% per year of exposure to combination antiretroviral treatment (CART). However, it remains unclear whether the observed increase in the rate of MI in this population can be attributed to changes in conventional cardiovascular risk factors. Objective To compare the number of MIs observed among participants in the D:A:D Study with the number predicted by assuming that conventional cardiovascular risk equations apply to patients with HIV infection. Methods The Framingham equation, a conventional cardiovascular risk algorithm, was applied to individual patient data in the D:A:D Study to predict rates of MI by duration of CART. A series of sensitivity analyses were performed to assess the effect of model and data assumptions. Predictions were extrapolated to provide 10-year risk estimates, and various scenarios were modelled to assess the expected effect of different interventions. Results In patients receiving CART, the observed numbers of MIs during D:A:D follow up were similar to or somewhat higher than predicted numbers: 9 observed vs 5.5 events predicted, 14 vs 9.8, 22 vs 14.9, 31 vs 23.2 and 47 vs 37.0 for < 1 year, 1-2 years, 2-3 years, 3-4 years and > 4 years CART exposure, respectively. In patients who had not received CART, the observed number of MIs was fewer than predicted (3 observed vs 7.6 predicted). Nine per cent of the study population have a predicted 10-year risk of MI above 10%, a level usually associated with initiation of intervention on risk factors. Conclusion A consistent feature of all analyses was that observed and predicted rates of MI increased in a parallel fashion with increased CART duration, suggesting that the observed increase in risk of MI may at least in part be explained by CART-induced changes in conventional risk factors. These findings provide guidance in terms of choosing lifestyle or therapeutic interventions to decrease those risk factors in much the same way as in persons without HIV infection.
引用
收藏
页码:218 / 230
页数:13
相关论文
共 48 条
[1]  
Aberg Judith A, 2003, J Int Assoc Physicians AIDS Care (Chic), V2 Suppl 2, pS24
[2]   CARDIOVASCULAR-DISEASE RISK PROFILES [J].
ANDERSON, KM ;
ODELL, PM ;
WILSON, PWF ;
KANNEL, WB .
AMERICAN HEART JOURNAL, 1991, 121 (01) :293-298
[3]   Efficacy and tolerability of pravastatin for the treatment of HIV-1 protease inhibitor-associated hyperlipidaemia: a pilot study [J].
Baldini, F ;
Di Giambenedetto, S ;
Cingolani, A ;
Murri, R ;
Ammassari, A ;
De Luca, A .
AIDS, 2000, 14 (11) :1660-1662
[4]   Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors [J].
Behrens, G ;
Dejam, A ;
Schmidt, H ;
Balks, HJ ;
Brabant, G ;
Körner, T ;
Stoll, M ;
Schmidt, RE .
AIDS, 1999, 13 (10) :F63-F70
[5]   A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors [J].
Carr, A ;
Samaras, K ;
Burton, S ;
Law, M ;
Freund, J ;
Chisholm, DJ ;
Cooper, DA .
AIDS, 1998, 12 (07) :F51-F58
[6]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[7]   Coronary heart disease in HIV-infected individuals [J].
Currier, JS ;
Taylor, A ;
Boyd, F ;
Dezii, CM ;
Kawabata, H ;
Burtcel, B ;
Maa, JF ;
Hodder, S .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 33 (04) :506-512
[8]  
*D A D COORD CTR, 2004, DAT COLL ADV EV ANT
[9]   European guidelines on cardiovascular disease prevention in clinical practice -: Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice [J].
De Backer, G ;
Ambrosioni, E ;
Borch-Johnsen, K ;
Brotons, C ;
Cifkova, R ;
Dallongeville, J ;
Ebrahim, S ;
Faergeman, O ;
Graham, I ;
Mancia, G ;
Cats, VM ;
Orth-Gomér, K ;
Perk, J ;
Pyörälä, K ;
Rodicio, JL ;
Sans, S ;
Sansoy, V ;
Sechtem, U ;
Silber, S ;
Thomsen, T ;
Wood, D .
EUROPEAN HEART JOURNAL, 2003, 24 (17) :1601-1610
[10]   Prediction of coronary heart disease: a comparison between the Copenhagen risk score and the Framingham risk score applied to a Dutch population [J].
de Visser, CL ;
Bilo, HJG ;
Thomsen, TF ;
Groenier, KH ;
Meyboom-De Jong, B .
JOURNAL OF INTERNAL MEDICINE, 2003, 253 (05) :553-562